After the Lockdown: A Global Coronavirus Vaccination Program…
The tendency is towards a Worldwide lockdown spearheaded by fear and media disinformation. Currently, hundreds of millions of people Worldwide are under lockdown.
What is the next step in the evolution of the COV-19 Crisis?
A coronavirus vaccine program was announced at Davos at the World Economic Forum (21-24 January) barely 2 weeks after the cornonavirus was identified by the Chinese authorities on January 7.
The lead entity for the novel coronavirus vaccine initiative is the Coalition for Epidemic Preparedness Innovations (CEPI) an organization sponsored and financed by the World Economic Forum (WEF) and the Bill and Melinda Gates Foundation.
Note the chronology: The development of the 2019 nCoV vaccine was announced at the Davos World Economic Forum (WEF) a week prior to the official launching by the WHO of a Worldwide Public Health Emergency (January 30) at a time when the number of “confirmed cases” Worldwide (outside China) was 150 (including 6 in the US).
CEPI is seeking a “monopoly” role in the vaccination business the objective of which is a “global vaccine project”, in partnership with a large number of “candidates”. It announced funding for its existing partnership with Inovio and The University of Queensland (Australia). In addition, CEPI confirmed (January 23) its contract with Moderna, Inc. and the U.S. National Institute of Allergy and Infectious Diseases (NIAID) headed by Dr. Anthony Fauci, who has been instrumental in waging the fear and panic campaign across America: “Ten Times Worse than Seasonal Flu”.
The Central Role of CEPI
CEPI is dealing simultaneously with several pharmaceutical companies. The Moderna- NIAID in all likelihood is slated to implement the COV-19 vaccine in the US.
On January 31st, the day following the WHO’s official launching of the pandemic and Trump’s decision to curtail air travel with China, CEPI announced its partnership with CureVac AG, a German-based biopharmaceutical company. A few days later, in early February, CEPI “announced that major vaccine manufacturer GSK would allow its proprietary adjuvants— compounds that boost the effectiveness of vaccines — to be used in the response”.
There are many “potential vaccines in the pipeline” with “dozens of research groups around the world racing to create a vaccine against COVID-19”.
In turn the EU and the US are currently competing for the vaccine markets on behalf of powerful pharmaceutical conglomerates, with the European Commission “offering up to €80 million in financial support to the CureVac AG” after it was reported that Trump “was attempting to secure exclusive access to a COVID-19 vaccine it is developing”, under the auspices of NIAID headed by Dr. Anthony Fauci.
The October Coronavirus Event 201 Simulation Exercise
The coronavirus was initially named 2019-nCoV by CEPI and the WHO: exactly the same name as that adopted in the WEF-Gates-John Hopkins Event 201 pertaining to a coronavirus simulation exercise held in Baltimore in mid October 2019.
The Event 201 John Hopkins simulation addressed the development of an effective vaccine in response to millions of cases (in the October 2019 simulation) of the 2019 nCoV. The simulation announced a scenario in which the entire population of the planet would be affected. “During the initial months of the pandemic, the cumulative number of cases [in the simulation] increases exponentially, doubling every week. And as the cases and deaths accumulate, the economic and societal consequences become increasingly severe.”
The scenario ends at the 18-month point, with 65 million deaths. The pandemic is beginning to slow due to the decreasing number of susceptible people. The pandemic will continue at some rate until there is an effective vaccine or until 80-90 % of the global population has been exposed. From that point on, it is likely to be an endemic childhood disease.
The COV-19 Global Vaccination Program
CEPI (on behalf of Gates-WEF, which funded the simulation exercise) is currently playing a key role in a large scale (global?) vaccination program in partnership with biotech companies, Big Pharma, government agencies as well as university laboratories.
“We’re having conversations with a broad array of potential partners. And critical to those conversations is: What’s the plan to make very large quantities of vaccine within a time frame that is potentially relevant to what people seem to be increasingly certain will be a pandemic, if it isn’t already there? … [Richard Hatchett, CEPI CEO in interview with stat.news.com]. …
The underlying focus is to develop a global vaccine.
And part of that was doing a global survey of manufacturing capacity to think about where we wanted to plant the manufacturing of any successful products we were able to bring forward.
Hackett confirms that the project commenced prior to the discovery and identification of the coronavirus in early January 2020:
“We did that in the last year or so. … We are
Article from LewRockwell